tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Promising Developments and Strategic Partnerships Drive Buy Rating for Seres Therapeutics
PremiumRatingsPromising Developments and Strategic Partnerships Drive Buy Rating for Seres Therapeutics
2M ago
Seres Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Seres Therapeutics Reports Q2 2025 Financial Results
2M ago
Seres Therapeutics Reports Q2 Results and Leadership Change
Premium
Company Announcements
Seres Therapeutics Reports Q2 Results and Leadership Change
2M ago
Seres Therapeutics presents expanded SER-155 biomarker data at ASCO meeting
PremiumThe FlySeres Therapeutics presents expanded SER-155 biomarker data at ASCO meeting
5M ago
Buy Rating Maintained for Seres Therapeutics Amid Promising SER-155 Developments and Financial Stability
Premium
Ratings
Buy Rating Maintained for Seres Therapeutics Amid Promising SER-155 Developments and Financial Stability
5M ago
Seres Therapeutics downgraded to Neutral from Buy at Chardan
Premium
The Fly
Seres Therapeutics downgraded to Neutral from Buy at Chardan
5M ago
MCRB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsMCRB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
Seres Therapeutics presents three posters at DDW Conference
Premium
The Fly
Seres Therapeutics presents three posters at DDW Conference
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100